INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Inspire Medical Systems, Inc. due to allegations of misleading statements regarding the launch of its Inspire V device, which has faced significant setbacks and resulted in a substantial drop in stock price [2][4][6]. Group 1: Legal Investigation - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in Inspire Medical to contact them to discuss their legal options [1]. - The firm is reminding investors of the January 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against Inspire Medical [2]. Group 2: Company Performance and Issues - Inspire Medical announced on August 4, 2025, that the launch of its Inspire V device faced significant delays due to treatment centers not completing necessary training and onboarding [5]. - The company also reported billing and reimbursement challenges, stating that while Medicare approved a CPT code for Inspire V, software updates for claims processing were not effective until July 1, 2025, leading to continued use of the older Inspire IV system [5]. - Inspire Medical's launch of Inspire V has been affected by weak demand and excess inventory, resulting in a more than 80% cut in its 2025 earnings guidance [6]. - Following these issues, Inspire Medical's stock price plummeted over 32% in one day, from $129.95 to $87.91, erasing approximately $1.2 billion in market capitalization [6].